Outlier test for reference replicate crossover study design [Regulatives / Guidelines]

posted by abhimanyu – Banglore, 2019-08-13 17:11 (2154 d 17:26 ago) – Posting: # 20494
Views: 3,533

Hello Helmut/All,

I have question regarding outlier test (Using Lund's method) for reference replicate crossover study design.

How can we find outlier? which one will be appropriate scenario for any regulatory point of view?

Scenario 1 : can we use test and individual reference (R R) to calculate standardized residual?

Scenario 2 : Can we use test and average of reference (average of R R) to calculate standardized residual?




Thanks in advance!

Abhimanyu

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,682 registered users;
60 visitors (0 registered, 60 guests [including 16 identified bots]).
Forum time: 10:37 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5